Dengue NS1 Rapid Test
- UID
- MFG/IVD/2023/000140_a0e9e4d381ee8fd2267ebb73b655a5ea_f22e210116cfc7ac7ee7713341cfb478
- Device class
- Class C
- Brand name
- Medlera
- License holder
- Medlera Healthcare
- Approving authority
- Central Drug Standards Control Organization, Ahmedabad
- Product information
- Dengue NS1 Rapid Test is a rapid immunochromatographic assay for the qualitative detection of NS1 antigen of Dengue virus in human whole blood, serum and plasma samples. The test is intended as an aid in the earlier diagnosis of dengue infection.
Dengue NS1 Rapid Test is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2023/000140_a0e9e4d381ee8fd2267ebb73b655a5ea_f22e210116cfc7ac7ee7713341cfb478. This device is marketed under the brand name Medlera. The license holder is Medlera Healthcare, and it is classified as Device Class Class C. The approving authority is Central Drug Standards Control Organization, Ahmedabad.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.